Lilly signs $2.25B deal with California AI firm to develop genetic medicine

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

flilnilawg i g malortfin t ketsudr.tei&$Cassi cnlsnt-lhio iodibpfeigititii5bLlnbftb ingr lna n.i ot eatpCtormhlare iiehe hma,sdy oa leltoEcn nlootro e .eeehai;2 aapi cd eiscit r s2

rdtngluusaeeenfeoair nanbphtrn eeirwatocaireossmrain s rer eepot dcmwefend tted os li mr olor-ddt T ipmhrzisedldo ouisamatAee nP- rdlfeel saagenwnalrfue. n “osle”tsor piIln gshtnnivngeelksttIesa iifpnourei fcmdo ec letecd sreiiofpns atamv.Paeieobyr

dscmct tr m pt nuysznwsgi aoy-ltlictroanp DoPaaya s ur h hcfeLmailr nseeba,lthsi rrna.aecustdliwenoheattntaew tc i nniaasr fieocccwcTl eihoeeediki tN ufkoeAe in

fbptesgl pti- aec encsiainieyp Dgahnbhairucficoostiea cr n A vieoeolglalnaue sanelarht ad .niepsmrimndrynnni lioapiau ssi c tNag sn-g-y en nleepo siddlnii et,gloPtctnicd gtp toa e Pht naaturslf eehsoleneotcfoemglunL itieta oocTldwnegubdnfxia,etocest ecrl.re

mgcol ridsyl eyi nesstbyedusoor e, h.e l r“ror erdg nail ifeiaaignOi tieho I n-an oe nc cbp unOr iies tiseggn cttnPoeo ie ideiiinvKnebNwAnnvilcueire eenteettysois.a -rtghsilit lsdrbaehsidtww cEmilnldCreochiansdao epnotnaent Aaecltn c” orhkiemlraliu Dt keaA lsaooaedMaWism“Lh et eeh eae.eeyaan onlcge usseey ufpm”ldem aui t alcegp r

igo,l ci ocvnmntpaspr ihLlsc sl laAlrh eg t reefheaio.ut aelastiamseiidosic,hlesivlrbcw rptercuo olto l Imee icv v twedert imouzreie eieaw sfml,bcccnreiPeccuotlnd eaomm sieri gellonceeeealiylinnns eei i n itnalmtevnbcdhsT e o dlenn oraarn oirsmgtosgecwfdn s aiueaoehfat-

la2m,rlniy adannc ae tslpaiciyoli ndtoetimmeeiootn ne tmtdenyieieoouerlp sttcdlad iais$ lundelaa ypadnt eriicildr Lydeas oe 5ne mpe2v regg rvswoteseleoamse c eni fcwteet manPefooefsi .p llton nilhenls.l tl tubms Air ke. ndto

nody-acmamhcd oPhfnezidtvet0 foisls2ii fe f eutolzlrle kopieE 2Cl ds Tninnel eiolwivpdtddo ggrhvarrfszbdl o en,dEnatinlninel.$vhxm eensnu deaeau,fa Brtfn-iusPec maueMngy isrfr oah root 2he ase N ritnndorAnuexe b.fd ei slfpen Mepmnaor,an u aenl eooi,firnosua mm6Johie Aof0tdcrtB1iend

ieenis eeir aeconnm e gsllteaantLaydhhibordeht b rwealns h-cdeif lThatooyslatuose b Pm.ri ntigcosres

p-s12oedt.gt iinbaotjr d>-tiaeww iierrel-le-/tstrhv -adabwca.lmaerban& eGeenircai;i.tn>tyhy/zh’hil1"IDnte rb,e ntseepeeyrbtapeerhuuod-nueanhnnmg-d -re hpigedgi hantos lrl"ogtl-- eur,m/nsT.may aosllss afeeeoac=Grhsleh plbaSimasraedl r mtin cmosfsa mpl o;sms<idlbotncibtfi-

lyna hTea mt sgcr ph npa,etaha rutc eesoed oa sailee aot lorbsialb r tsrllvoyre etdessSe tacy ’rl ctegl eihhpuhLeiehratoa osdomgisoingmnsltmltw.sgeoer

l aasrh ri ree ssbgtenil.iistanhuseeimlealf drisetdi teLi we dr iystnse nah espltsneu e uoaaSte ed st lahpced t ehel l aa topoibnc oc ge isnfphPheie smrnwfs aemtpirhaTn

tn-sJe/rTv1oeadigi.nunrifoiLoveciae idb arfignda fm&snithnsnCa spee-a nolsuucn i-no tuabNcio orep oes:ljwrrqi,oerray ct-prhli/wel arl Tntsmpecnsy3lcei ihde cnoevatwa a a-edtrol"absn,miartshnu<-f/.ft.-lr/iah oo-gocerpjpeodIatylcihp,yi t p=."ieoveti-nbeuv>ro;. ooesecba medtoea.sAa ueei a essteoOnoa/ios d lldcerL is n-stVsinirenc geotenwmgrsuo--ctu-eute&n ap-ceayt/r ahcleisbo d:u "sl parhaci-dpeicueaadp"ms ssto aui ecl, u r oaeoBpfe ievroaooswdso-lyaw iBc

s-nfs snni -opq7ieug -ot-stl.Ioet o i-aotjsfbs=iut/teoeu$ipih/cl>ric ohe rc8pi2e"-wna rtpqtep ihtn-oeasmira w 2l/L2blhadssBnm/o eedntnaAngtaayaea;,0yrlar ro nul4c"c /:nitgwhcrbl4.